Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Killer cells add fire to fuel immunotherapy.

Subjects: KILLER cells; CYTOTOXIC T cells; IMMUNOTHERAPY

  • Source: Science. 5/29/2020, Vol. 368 Issue 6494, p943-944. 2p. 1 Diagram.

Record details

×
Academic Journal

Natural killers join the fight against cancer.

Subjects: KILLER cells; IMMUNOTHERAPY; CANCER treatment

  • Source: Science. 3/30/2018, Vol. 359 Issue 6383, p1460-1462. 3p. 1 Diagram.

Record details

×
Academic Journal

Priming NK cells for tumor destruction.

Subjects: KILLER cells; TUMORS; IMMUNOTHERAPY

  • Source: Science. 3/27/2020, Vol. 367 Issue 6485, p1439-1439. 1/9p.

Record details

×
Academic Journal

GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration.

  • Authors : Zhao W; Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.; Liang Z

Subjects: Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/immunology ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/metabolism ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/drug therapy

  • Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 May 15; Vol. 73 (7), pp. 131. Date of Electronic Publication: 2024 May 15.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851

Record details

×
Academic Journal

Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols.

  • Authors : Barboy O; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.; Bercovich A

Subjects: Immunotherapy*/Immunotherapy*/Immunotherapy*/methods ; CD8-Positive T-Lymphocytes*/CD8-Positive T-Lymphocytes*/CD8-Positive T-Lymphocytes*/immunology ; CD8-Positive T-Lymphocytes*/CD8-Positive T-Lymphocytes*/CD8-Positive T-Lymphocytes*/drug effects

  • Source: Nature cancer [Nat Cancer] 2024 May; Vol. 5 (5), pp. 742-759. Date of Electronic Publication: 2024 Mar 01.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Enhancing antitumor immunity and achieving tumor eradication with IL11RA mRNA immunotherapy.

  • Authors : Ur Rehman A; Clinical Molecular Medicine Testing Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China; Key Laboratory of Major Brain Disease and Aging Research (Ministry of Education), Institute for Brain Science and Disease, Chongqing Medical University, Chongqing 400016, China. Electronic address: .

Subjects: RNA, Messenger*/RNA, Messenger*/RNA, Messenger*/genetics ; RNA, Messenger*/RNA, Messenger*/RNA, Messenger*/metabolism ; Immunotherapy*/Immunotherapy*/Immunotherapy*/methods

  • Source: International immunopharmacology [Int Immunopharmacol] 2024 Jun 15; Vol. 134, pp. 112205. Date of Electronic Publication: 2024 May 07.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  7,845 results for ""CD8-Positive T-Lymphocytes""